RaySearch Laboratories Licenses Technology for Automated Treatment Planning From University Health Network's Princess Margaret Cancer Center
9/19/2012 8:59:43 AM
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (publ.)(STO:RAYB) has entered into an exclusive license agreement with University Health Network’s Princess Margaret Cancer Centre in Toronto, Canada regarding techniques for automated planning of breast cancer treatments. The Princess Margaret has for a long time developed and refined a technique for automated planning of intensity modulated radiation therapy (IMRT) for breast cancer patients. The technique emulates the often time-consuming steps that are performed during treatment planning including organ segmentation, beam optimization, IMRT optimization and dose calculation. Therefore, dosimetrists can produce complete clinical treatment plans and automated quality assurance reporting in just a few minutes instead of spending up to several hours on each plan. The Princess Margaret has been using this technology clinically for a number of years and validated these techniques in extensive studies demonstrating considerable time saving and also equivalent or better plan quality compared with standard manual planning.